Researchers at the University of Colorado's Anschutz Medical Campus have lost two scientific grants since President Donald ...

In an attempt to strike a pitch-perfect tone with Generation X, Pfizer has recruited Elizabeth Banks as the face of a new ...

Papenfus now praises the investment in research that, he believes, advanced science by decades in just a few years.

After spending years unsuccessfully attempting to develop a Covid-19 vaccine, Inovio is now reporting promising results from ...

Shares of vaccine-maker Moderna MRNA closed at $34.71 on Monday, close to their 52-week low of $29.25. Moderna is facing several headwinds, including the declining COVID-19 vaccine and the soft sales ...

Contract Development and Manufacturing Organizations (CDMOs) enhance drug discovery by providing essential services that reduce costs and accelerate production.

Scientists say that officials from the National Institutes of Health urged them to remove references to mRNA vaccine technology ...

The Australian Human Rights Commission recently published a report entitled Collateral Damage: What the untold stories from ...

The drugmaker has revamped how it packages, promotes and sells certain medicines in an effort to overcome a postpandemic ...

NIH officials also told a senior NIH-funded vaccine scientist in New York state, who does not conduct mRNA vaccine research ...

Four Goldman Sachs stock picks make sense for growth and income investors charting a course for the rest of what could be a ...